Senators Urge HHS to Address Risks of Prediction Markets Linked to Drug Trials

Senators Urge HHS to Address Risks of Prediction Markets Linked to Drug Trials

Two Democratic senators have raised urgent concerns with the Department of Health and Human Services regarding the operation of prediction market contracts related to clinical trials and drug approvals. In a letter obtained by CNBC, Senator Angela Alsobrooks of Maryland and Senator Ron Wyden of Oregon addressed HHS Secretary Robert F. Kennedy Jr., pressing the department to outline measures taken to mitigate risks associated with these markets.

The lawmakers argued that allowing public betting on the success of medical trials undermines the scientific process and creates perverse incentives for researchers. They warned that such markets could harm trial participants and lead to dangerous medical outcomes for many Americans.

Specific concerns included the potential influence of these markets on patient decisions regarding trial participation, echoing worries previously voiced by healthcare professionals. Additionally, the senators highlighted the risk of insider trading, suggesting that researchers and regulators with access to nonpublic information could exploit the markets for financial gain.

As part of their communication request, the senators asked HHS to disclose all internal communications regarding staff participation in these prediction markets. They also sought details on any interactions between the department and prediction market platforms or the Commodity Futures Trading Commission (CFTC), which regulates event contracts. Furthermore, the lawmakers requested any internal analyses conducted by the department evaluating the potential impact of these markets.

Kalshi, a company that offers such event contracts in the United States, stated that it has implemented guardrails to maintain market integrity in response to similar concerns.

6 responses to “Senators Urge HHS to Address Risks of Prediction Markets Linked to Drug Trials”

Leave a Reply

Your email address will not be published. Required fields are marked *